ZYBERNO
Stock Report
Updated Sep 1, 2026

LONGEVERON INC. (LGVN)

Healthcare • NASDAQ

$6.90

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
25.0/100
POOR BUSINESS
LONGEVERON INC. (LGVN) scores 25/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-223.2%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.11x)
Operating Margin (Operational Efficiency):CRITICAL (-1,992.8%)
Return on Capital (Capital Efficiency):CRITICAL (-1,193.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

LONGEVERON INC. (LGVN) stock report — Zyberno Score 25/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, LGVN generated -$18.54M in Owner Earnings. Capital was deployed as follows: $218.00K invested in capital expenditures. Reinvestment rate: 3.1%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:6.90
Market Cap:$216.51M

Valuation Multiples (3)

P/B Ratio:20.81x
P/S Ratio:182.40x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$207.59M

Price Action & Momentum (1)

% of 52-Week High:56.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-150.2%
Reinvestment Rate:3.1%
Fundamental Growth Rate (g):-37.3%

Margin Analysis (3)

Operating Margin Ttm:-1,992.8%
Net Margin Ttm:-1,977.6%
Ebitda Margin:-1,925.4%

TTM Performance (3)

Gross Margin Ttm:69.8%
Operating Margin Ttm:-1,992.8%
Net Margin Ttm:-1,977.6%

Yield Metrics (2)

Earnings Yield:-$135.15
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:44.5%
Latest Earnings Filed:2026-08-12

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-29.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.63x
Quick Ratio:2.63x
Cash Ratio:2.34x

Leverage Analysis (3)

Debt To Equity Ttm:0.11x
Debt-to-Equity Ratio:0.11x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,016,000.00
Cash And Cash Equivalents:10,077,000.00
Long Term Debt:$581.00K
Net Debt:-$8.92M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.19M
Linear Growth: -29.8%
📊 Click to view full LGVN Revenue analysis & methodology →
Cost Of Revenue Ttm:$359.00K

Profitability Breakdown (2)

Gross profit TTM: $828.00K
Linear Growth: 27.6%
📊 Click to view full LGVN Gross Profit analysis & methodology →
-$23.66M

Bottom Line Performance (3)

-$23.47M
Income Before Tax:$0.00
Ebitda Ttm:-22,855,000.00

Operating Expenses (5)

Operating Expenses:24,483,000.00
R And D Expense:12,085,000.00
Sga Expense:12,398,000.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:4,210.8%
Sga To Revenue Percentage:4,319.9%
Ebitda Margin:-1,925.4%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$15.49M
Current Assets:$11.32M
Ppe Net:7,795,000.00
Goodwill:0.00
Intangible Assets:$2.20M

Liability Structure (4)

Total Liabilities:5,085,000.00
Current Liabilities:4,307,000.00
Long Term Debt:$581.00K
Short Term Debt:$581.00K

Equity & Capital (3)

Equity:$10.40M
Retained Earnings:-$143.12M
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:65,000.00
Inventory:0.00
Accounts Payable:2,653,000.00

Special Items (2)

Contract Liabilities:40,000.00
Stock Based Compensation:379,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$18.32M-$18.54M

Investment Activities (2)

Investing Cash Flow:-$20.00K
Capital Expenditures Ttm:218,000.00

Financing Activities (3)

Financing Cash Flow:$15.49M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:12,866,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:800,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.00
-$1.00
Earnings Per Share Ttm:-$0.75

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.04
Operating Cash Flow Per Share:-$0.59

Book Value & Capital (2)

Book Value Per Share:$0.33
Cash Per Share:0.32

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.08x
Working Capital Turnover Ttm:0.17x

Receivables Management (2)

Receivables Turnover Ttm:18.26x
Days Sales Outstanding Ttm:19.99

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:2,697.34
Cash Conversion Cycle:-3,676.35
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$18.54M

Damodaran Growth Analysis (2)

Reinvestment Rate:3.1%
Fundamental Growth Rate (g):-37.3%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-29.8%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):27.6%
Book Value Growth Rate (Linear):-17.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:LGVN
Company Name:LONGEVERON INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:31.38M
Shares Outstanding Basic:31.38M
Shares Outstanding Diluted:31.38M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 10:26:09 UTC
Data Timestamp:2026-08-21T01:30:22.015804
Scroll to Top